Created
August 7, 2020 06:53
-
-
Save titipata/79c18404a78c5823242b0bfe073e0206 to your computer and use it in GitHub Desktop.
This file contains hidden or bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
| Theme1 | Topic1 | SubTopic1 | n_submission | |
|---|---|---|---|---|
| Theme A: Development | A.01. Neurogenesis and Gliogenesis | A.01.a. Nervous system patterning and developmental cell death | 13 | |
| Theme A: Development | A.01. Neurogenesis and Gliogenesis | A.01.b. Proliferation: Self-renewal and cell cycle | 10 | |
| Theme A: Development | A.01. Neurogenesis and Gliogenesis | A.01.c. Proliferation: Molecular mechanisms | 10 | |
| Theme A: Development | A.01. Neurogenesis and Gliogenesis | A.01.d. Cell lineage | 17 | |
| Theme A: Development | A.01. Neurogenesis and Gliogenesis | A.01.e. Mechanisms of cell fate | 31 | |
| Theme A: Development | A.01. Neurogenesis and Gliogenesis | A.01.f. Cell migration | 18 | |
| Theme A: Development | A.01. Neurogenesis and Gliogenesis | A.01.g. Neuronal differentiation | 31 | |
| Theme A: Development | A.01. Neurogenesis and Gliogenesis | A.01.h. Glial differentiation and interaction with neurons | 21 | |
| Theme A: Development | A.02. Postnatal Neurogenesis | A.02 b. Postnatal neurogenesis: Molecular mechanisms | 23 | |
| Theme A: Development | A.02. Postnatal Neurogenesis | A.02 c. Postnatal neurogenesis: Environmental and pharmacological regulation | 33 | |
| Theme A: Development | A.02. Postnatal Neurogenesis | A.02.a. Postnatal neurogenesis: Temporal and spatial patterns | 12 | |
| Theme A: Development | A.03. Stem Cells and Reprogramming | A.03.a. Induced pluripotent stem cells: Disease models | 29 | |
| Theme A: Development | A.03. Stem Cells and Reprogramming | A.03.b. Induced pluripotent stem cells: Biology | 4 | |
| Theme A: Development | A.03. Stem Cells and Reprogramming | A.03.c. Neural differentiation of pluripotent stem cells | 20 | |
| Theme A: Development | A.04. Transplantation and Regeneration | A.04.a. Transplantation | 18 | |
| Theme A: Development | A.04. Transplantation and Regeneration | A.04.b. Regeneration: PNS | 13 | |
| Theme A: Development | A.04. Transplantation and Regeneration | A.04.c. Regeneration: CNS | 23 | |
| Theme A: Development | A.05. Axon and Dendrite Development | A.05.a. Axon growth and guidance: Adhesion and cytoskeletal dynamics | 13 | |
| Theme A: Development | A.05. Axon and Dendrite Development | A.05.b. Axon growth and guidance: Intrinsic mechanisms | 28 | |
| Theme A: Development | A.05. Axon and Dendrite Development | A.05.c. Axon growth and guidance: Extrinsic mechanisms | 14 | |
| Theme A: Development | A.05. Axon and Dendrite Development | A.05.d. Dendritic growth and branching | 24 | |
| Theme A: Development | A.06. Synaptogenesis and Activity-Dependent Development | A.06.a. Synapse formation | 30 | |
| Theme A: Development | A.06. Synaptogenesis and Activity-Dependent Development | A.06.b. Synapse maturation and remodeling | 17 | |
| Theme A: Development | A.06. Synaptogenesis and Activity-Dependent Development | A.06.c. Neural circuit maturation and remodeling | 44 | |
| Theme A: Development | A.06. Synaptogenesis and Activity-Dependent Development | A.06.d. Other activity-dependent processes | 7 | |
| Theme A: Development | A.07. Developmental Disorders | A.07.a. Autism: Behavioral analysis | 34 | |
| Theme A: Development | A.07. Developmental Disorders | A.07.b. Autism: Genetic models | 33 | |
| Theme A: Development | A.07. Developmental Disorders | A.07.c. Autism: Synaptic and cellular mechanisms | 33 | |
| Theme A: Development | A.07. Developmental Disorders | A.07.d. Autism: Environment and pathology | 23 | |
| Theme A: Development | A.07. Developmental Disorders | A.07.e. Autism: Physiology and systems | 36 | |
| Theme A: Development | A.07. Developmental Disorders | A.07.f. Rett syndrome | 11 | |
| Theme A: Development | A.07. Developmental Disorders | A.07.g. Fragile X | 40 | |
| Theme A: Development | A.07. Developmental Disorders | A.07.h. Down syndrome | 11 | |
| Theme A: Development | A.07. Developmental Disorders | A.07.i. Angelman and other developmental disorders | 9 | |
| Theme A: Development | A.07. Developmental Disorders | A.07.j. ADHD, SLI, dyslexia and other specific disorders of neurobehavior | 23 | |
| Theme A: Development | A.07. Developmental Disorders | A.07.k. Animal models | 79 | |
| Theme A: Development | A.07. Developmental Disorders | A.07.l. Mechanisms | 50 | |
| Theme A: Development | A.08. Development of Motor, Sensory, and Limbic Systems | A.08.a. Motor systems | 14 | |
| Theme A: Development | A.08. Development of Motor, Sensory, and Limbic Systems | A.08.b. Sensory systems | 45 | |
| Theme A: Development | A.08. Development of Motor, Sensory, and Limbic Systems | A.08.c. Limbic system | 8 | |
| Theme A: Development | A.09. Adolescent Development | A.09.a. Animal models | 40 | |
| Theme A: Development | A.09. Adolescent Development | A.09.b. Human imaging | 24 | |
| Theme A: Development | A.09. Adolescent Development | A.09.c. Mechanisms of vulnerability | 11 | |
| Theme A: Development | A.10. Development and Evolution | A.10.a. Comparative anatomy | 29 | |
| Theme A: Development | A.10. Development and Evolution | A.10.b. Comparative molecular mechanisms | 6 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.01. Neurotransmitters and Signaling Molecules | B.01.a. Amino acids | 7 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.01. Neurotransmitters and Signaling Molecules | B.01.b. Monoamines | 29 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.01. Neurotransmitters and Signaling Molecules | B.01.c. Other small-molecule neurotransmitters and messengers | 9 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.01. Neurotransmitters and Signaling Molecules | B.01.d. Opiates, cytokines, and other neuropeptides | 13 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.01. Neurotransmitters and Signaling Molecules | B.01.e. Neurotrophins | 19 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.01. Neurotransmitters and Signaling Molecules | B.01.f. Comparative neurotransmitters | 4 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.02. Ligand-Gated Ion Channels | B.02.a. Nicotinic acetylcholine receptors in brain: Physiology and function | 18 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.02. Ligand-Gated Ion Channels | B.02.b. Nicotinic acetylcholine receptors: Structure and regulation | 11 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.02. Ligand-Gated Ion Channels | B.02.c. NMDA receptors | 41 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.02. Ligand-Gated Ion Channels | B.02.d. Non-NMDA receptors | 11 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.02. Ligand-Gated Ion Channels | B.02.e. GABA(A) receptors | 37 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.02. Ligand-Gated Ion Channels | B.02.f. Glycine receptors & other ligand gated ion channels | 10 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.03. G-Protein Coupled Receptors | B.03.a. Metabotropic glutamate and GABA B receptors | 21 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.03. G-Protein Coupled Receptors | B.03.b. Peptide receptors | 13 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.03. G-Protein Coupled Receptors | B.03.c. Other metabotropic receptors | 23 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.04. Ion Channels | B.04.a. Sodium channels | 28 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.04. Ion Channels | B.04.b. Calcium channels | 36 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.04. Ion Channels | B.04.c. Potassium channels | 42 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.04. Ion Channels | B.04.d. HCN, TRP channels, and non-selective cation channels | 17 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.04. Ion Channels | B.04.e. Mechanosensitive channels | 3 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.04. Ion Channels | B.04.f. Other ion channels | 8 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.05. Transporters | B.05.a. Glutamate | 17 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.05. Transporters | B.05.b. Monoamine | 17 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.05. Transporters | B.05.c. Other | 15 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.06. Neurotransmitter Release | B.06.a. Vesicle docking, fusion, recycling, biogenesis | 26 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.06. Neurotransmitter Release | B.06.b. Presynaptic organization and structure | 24 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.07. Synaptic Transmission | B.07.a. Postsynaptic organization and structure | 26 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.07. Synaptic Transmission | B.07.b. Synaptic integration | 26 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.07. Synaptic Transmission | B.07.c. Electrical synapses and gap junctions | 5 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.07. Synaptic Transmission | B.07.d. Modulation: Peptides and amines | 3 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.07. Synaptic Transmission | B.07.e. Modulation: ACh, amino acids, and GABA | 22 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.07. Synaptic Transmission | B.07.f. Modulation: Mechanisms of action | 11 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.07. Synaptic Transmission | B.07.g. Modulation: Pharmacology | 18 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.08. Synaptic Plasticity | B.08.a. Short-term plasticity | 15 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.08. Synaptic Plasticity | B.08.b. LTP: Kinases and intracellular signaling | 25 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.08. Synaptic Plasticity | B.08.c. LTP: Pre- and Postsynaptic mechanisms | 33 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.08. Synaptic Plasticity | B.08.d. Long-term depression (LTD) | 18 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.08. Synaptic Plasticity | B.08.e. Spike-timing dependent plasticity | 12 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.08. Synaptic Plasticity | B.08.f. Homeostatic plasticity | 27 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.08. Synaptic Plasticity | B.08.g. Structural plasticity | 45 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.08. Synaptic Plasticity | B.08.h. Transcription and translation in plasticity | 30 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.08. Synaptic Plasticity | B.08.i. Other | 28 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.09. Physiological Properties of Neurons | B.09.a. Neural oscillators, dendritic properties, and plasticity | 32 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.09. Physiological Properties of Neurons | B.09.b. Modulation of neuronal firing properties | 55 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.10. Network Interactions | B.10.a. Signal propagation | 15 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.10. Network Interactions | B.10.b. Oscillations and synchrony: Unit studies | 15 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.10. Network Interactions | B.10.c. Oscillations and synchrony: EEG studies | 20 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.10. Network Interactions | B.10.d. Oscillations and synchrony: LFP studies | 20 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.10. Network Interactions | B.10.e. Network interactions: Other | 35 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.11. Epilepsy | B.11.a. Genetics | 14 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.11. Epilepsy | B.11.b. Channels | 9 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.11. Epilepsy | B.11.c. Synaptic mechanisms | 19 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.11. Epilepsy | B.11.d. Networks | 29 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.11. Epilepsy | B.11.e. Post-seizure modifications | 10 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.11. Epilepsy | B.11.f. In vivo and behavior | 23 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.11. Epilepsy | B.11.g. Animal Models | 57 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.11. Epilepsy | B.11.h. Anticonvulsant and antiepileptic therapies | 42 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.11. Epilepsy | B.11.i. Human Studies | 27 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.12. Glial Mechanisms | B.12.a. Astrocytes: Biology | 30 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.12. Glial Mechanisms | B.12.b. Astrocytes: Disease mechanisms | 27 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.12. Glial Mechanisms | B.12.c. Microglia: Biology | 22 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.12. Glial Mechanisms | B.12.d. Microglia: Disease mechanisms | 25 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.12. Glial Mechanisms | B.12.e. Oligodendrocytes | 18 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.12. Glial Mechanisms | B.12.f. Glia-neuron interactions: CNS | 56 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.12. Glial Mechanisms | B.12.g. Glia-neuron interactions: PNS | 12 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.13. Demyelinating Disorders | B.13.a. Molecular and cellular mechanisms | 17 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.13. Demyelinating Disorders | B.13.b. Therapeutics | 9 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.13. Demyelinating Disorders | B.13.c. Human and animal studies | 14 | |
| Theme B: Neural Excitability, Synapses, and Glia | B.14. Neuro-Oncology | B.14.a. Neuro-oncology | 24 | |
| Theme C: Neurodegenerative Disorders and Injury | C.01. Brain Wellness and Aging | C.01.a. Molecular mechanisms | 11 | |
| Theme C: Neurodegenerative Disorders and Injury | C.01. Brain Wellness and Aging | C.01.b. Metabolism, oxidative stress, and cellular mechanisms | 27 | |
| Theme C: Neurodegenerative Disorders and Injury | C.01. Brain Wellness and Aging | C.01.c. Pharmacological interventions | 5 | |
| Theme C: Neurodegenerative Disorders and Injury | C.01. Brain Wellness and Aging | C.01.d. Non-pharmacological and lifestyle interventions | 14 | |
| Theme C: Neurodegenerative Disorders and Injury | C.01. Brain Wellness and Aging | C.01.e. Systemic factors and brain function | 11 | |
| Theme C: Neurodegenerative Disorders and Injury | C.01. Brain Wellness and Aging | C.01.f. Brain wellness | 13 | |
| Theme C: Neurodegenerative Disorders and Injury | C.02. Alzheimer's Disease and Other Dementias | C.02.a. Alzheimer's disease: -Omics approaches | 18 | |
| Theme C: Neurodegenerative Disorders and Injury | C.02. Alzheimer's Disease and Other Dementias | C.02.b. Genetics and functional genomics | 12 | |
| Theme C: Neurodegenerative Disorders and Injury | C.02. Alzheimer's Disease and Other Dementias | C.02.c. Alzheimer's disease: Genetic analyses | 9 | |
| Theme C: Neurodegenerative Disorders and Injury | C.02. Alzheimer's Disease and Other Dementias | C.02.d. Biochemistry approaches and mechanisms | 49 | |
| Theme C: Neurodegenerative Disorders and Injury | C.02. Alzheimer's Disease and Other Dementias | C.02.e. APP secretase activity: Alpha, beta, gamma | 5 | |
| Theme C: Neurodegenerative Disorders and Injury | C.02. Alzheimer's Disease and Other Dementias | C.02.f. APP and metabolites: Function and processing | 13 | |
| Theme C: Neurodegenerative Disorders and Injury | C.02. Alzheimer's Disease and Other Dementias | C.02.g. APP/Abeta: Animal and cellular models | 46 | |
| Theme C: Neurodegenerative Disorders and Injury | C.02. Alzheimer's Disease and Other Dementias | C.02.h. Abeta biochemistry | 5 | |
| Theme C: Neurodegenerative Disorders and Injury | C.02. Alzheimer's Disease and Other Dementias | C.02.i. In vitro Abeta toxicity | 7 | |
| Theme C: Neurodegenerative Disorders and Injury | C.02. Alzheimer's Disease and Other Dementias | C.02.j. Abeta-tau interactions | 9 | |
| Theme C: Neurodegenerative Disorders and Injury | C.02. Alzheimer's Disease and Other Dementias | C.02.k. Abeta as a therapeutic target | 11 | |
| Theme C: Neurodegenerative Disorders and Injury | C.02. Alzheimer's Disease and Other Dementias | C.02.l. Proteinopathy and pathology other than Abeta/tau | 7 | |
| Theme C: Neurodegenerative Disorders and Injury | C.02. Alzheimer's Disease and Other Dementias | C.02.m. Tau: Biochemistry and physiology | 12 | |
| Theme C: Neurodegenerative Disorders and Injury | C.02. Alzheimer's Disease and Other Dementias | C.02.n. Tau: Animal and cellular models | 16 | |
| Theme C: Neurodegenerative Disorders and Injury | C.02. Alzheimer's Disease and Other Dementias | C.02.o. Tau: Imaging and pathology/preclinical and clinical | 1 | |
| Theme C: Neurodegenerative Disorders and Injury | C.02. Alzheimer's Disease and Other Dementias | C.02.p. ApoE and associated pathways | 13 | |
| Theme C: Neurodegenerative Disorders and Injury | C.02. Alzheimer's Disease and Other Dementias | C.02.q. Synaptic mechanisms and deficits in Alzheimer's disease | 41 | |
| Theme C: Neurodegenerative Disorders and Injury | C.02. Alzheimer's Disease and Other Dementias | C.02.r. Alzheimer's disease: Neuroinflammation and immune actions | 38 | |
| Theme C: Neurodegenerative Disorders and Injury | C.02. Alzheimer's Disease and Other Dementias | C.02.s. Therapeutic strategies: Preclinical | 72 | |
| Theme C: Neurodegenerative Disorders and Injury | C.02. Alzheimer's Disease and Other Dementias | C.02.t. Clinical and pre-clinical imaging studies in Alzheimer's disease | 17 | |
| Theme C: Neurodegenerative Disorders and Injury | C.02. Alzheimer's Disease and Other Dementias | C.02.u. Biomarkers | 25 | |
| Theme C: Neurodegenerative Disorders and Injury | C.02. Alzheimer's Disease and Other Dementias | C.02.v. Cognitive function | 16 | |
| Theme C: Neurodegenerative Disorders and Injury | C.02. Alzheimer's Disease and Other Dementias | C.02.w. Alzheimer's disease: Therapeutic approaches: Clinical | 9 | |
| Theme C: Neurodegenerative Disorders and Injury | C.02. Alzheimer's Disease and Other Dementias | C.02.x. Other dementias | 21 | |
| Theme C: Neurodegenerative Disorders and Injury | C.03. Parkinson’s Disease | C.03.a. Cellular mechanisms | 42 | |
| Theme C: Neurodegenerative Disorders and Injury | C.03. Parkinson’s Disease | C.03.b. Mitochondrial mechanisms and genetics | 16 | |
| Theme C: Neurodegenerative Disorders and Injury | C.03. Parkinson’s Disease | C.03.c. Dopamine and non-dopamine pathways | 35 | |
| Theme C: Neurodegenerative Disorders and Injury | C.03. Parkinson’s Disease | C.03.d. LRRK2 mechanisms, targets and pathways | 13 | |
| Theme C: Neurodegenerative Disorders and Injury | C.03. Parkinson’s Disease | C.03.e. Alpha-synuclein: Models, mechanisms and transmission | 65 | |
| Theme C: Neurodegenerative Disorders and Injury | C.03. Parkinson’s Disease | C.03.f. Vps35 and retromers | 2 | |
| Theme C: Neurodegenerative Disorders and Injury | C.03. Parkinson’s Disease | C.03.g. Circuit mechanisms | 19 | |
| Theme C: Neurodegenerative Disorders and Injury | C.03. Parkinson’s Disease | C.03.h. Transgenic animal models | 12 | |
| Theme C: Neurodegenerative Disorders and Injury | C.03. Parkinson’s Disease | C.03.i. Rat and mouse toxin and behavior models | 29 | |
| Theme C: Neurodegenerative Disorders and Injury | C.03. Parkinson’s Disease | C.03.j. Mechanisms and degeneration treatment | 20 | |
| Theme C: Neurodegenerative Disorders and Injury | C.03. Parkinson’s Disease | C.03.k. Neuroprotective mechanisms | 41 | |
| Theme C: Neurodegenerative Disorders and Injury | C.03. Parkinson’s Disease | C.03.l. Preclinical therapeutic development | 43 | |
| Theme C: Neurodegenerative Disorders and Injury | C.03. Parkinson’s Disease | C.03.m. Human studies | 48 | |
| Theme C: Neurodegenerative Disorders and Injury | C.03. Parkinson’s Disease | C.03.n. Human studies: Genetics and diagnostic | 7 | |
| Theme C: Neurodegenerative Disorders and Injury | C.03. Parkinson’s Disease | C.03.o. Human studies: Therapeutics | 7 | |
| Theme C: Neurodegenerative Disorders and Injury | C.03. Parkinson’s Disease | C.03.p. Clinical therapies | 5 | |
| Theme C: Neurodegenerative Disorders and Injury | C.04. Movement Disorders | C.04.a. Huntington's disease: Mechanisms and more | 52 | |
| Theme C: Neurodegenerative Disorders and Injury | C.04. Movement Disorders | C.04.b. Huntington's disease: Animal models | 18 | |
| Theme C: Neurodegenerative Disorders and Injury | C.04. Movement Disorders | C.04.c. Repeat expansion diseases: Non-Huntington’s disease | 8 | |
| Theme C: Neurodegenerative Disorders and Injury | C.04. Movement Disorders | C.04.d. Ataxias | 23 | |
| Theme C: Neurodegenerative Disorders and Injury | C.04. Movement Disorders | C.04.e. Dystonia | 15 | |
| Theme C: Neurodegenerative Disorders and Injury | C.04. Movement Disorders | C.04.f. Other movement disorders | 28 | |
| Theme C: Neurodegenerative Disorders and Injury | C.05. Neuromuscular Diseases | C.05.a. Motor neuron disease: Human genetics and cellular mechanisms | 21 | |
| Theme C: Neurodegenerative Disorders and Injury | C.05. Neuromuscular Diseases | C.05.b. Motor neuron disease: In vitro studies | 25 | |
| Theme C: Neurodegenerative Disorders and Injury | C.05. Neuromuscular Diseases | C.05.c. Motor neuron disease: Animal models | 42 | |
| Theme C: Neurodegenerative Disorders and Injury | C.05. Neuromuscular Diseases | C.05.d. Motor neuron disease: Therapeutics | 26 | |
| Theme C: Neurodegenerative Disorders and Injury | C.05. Neuromuscular Diseases | C.05.e. Other neuromuscular diseases | 13 | |
| Theme C: Neurodegenerative Disorders and Injury | C.06. Neurotoxicity, Inflammation, and Neuroprotection | C.06.a. Cell death mechanisms: Apoptosis and calcium | 8 | |
| Theme C: Neurodegenerative Disorders and Injury | C.06. Neurotoxicity, Inflammation, and Neuroprotection | C.06.b. Cell death mechanisms: Oxidative stress and mitochondria | 24 | |
| Theme C: Neurodegenerative Disorders and Injury | C.06. Neurotoxicity, Inflammation, and Neuroprotection | C.06.c. Neuroprotective mechanisms: Preclinical | 73 | |
| Theme C: Neurodegenerative Disorders and Injury | C.06. Neurotoxicity, Inflammation, and Neuroprotection | C.06.d. Neuroprotective mechanisms: Clinical | 4 | |
| Theme C: Neurodegenerative Disorders and Injury | C.06. Neurotoxicity, Inflammation, and Neuroprotection | C.06.e. Neurotoxicity and neurodegeneration | 81 | |
| Theme C: Neurodegenerative Disorders and Injury | C.06. Neurotoxicity, Inflammation, and Neuroprotection | C.06.f. Neuroinflammation: Microglia | 46 | |
| Theme C: Neurodegenerative Disorders and Injury | C.06. Neurotoxicity, Inflammation, and Neuroprotection | C.06.g. Neuroinflammation: Beyond microglia | 23 | |
| Theme C: Neurodegenerative Disorders and Injury | C.06. Neurotoxicity, Inflammation, and Neuroprotection | C.06.h. Neuroinflammation: Neurodegeneration | 47 | |
| Theme C: Neurodegenerative Disorders and Injury | C.06. Neurotoxicity, Inflammation, and Neuroprotection | C.06.i. Neuroinflammation: Animal models | 36 | |
| Theme C: Neurodegenerative Disorders and Injury | C.06. Neurotoxicity, Inflammation, and Neuroprotection | C.06.j. Neuroinflammation: HIV and infections | 37 | |
| Theme C: Neurodegenerative Disorders and Injury | C.07. Ischemia | C.07.a. Molecular mechanisms | 24 | |
| Theme C: Neurodegenerative Disorders and Injury | C.07. Ischemia | C.07.b. Cellular mechanisms | 17 | |
| Theme C: Neurodegenerative Disorders and Injury | C.07. Ischemia | C.07.c. Ischemia: Perinatal | 11 | |
| Theme C: Neurodegenerative Disorders and Injury | C.07. Ischemia | C.07.d. Ischemia: Recovery | 15 | |
| Theme C: Neurodegenerative Disorders and Injury | C.07. Ischemia | C.07.e. Ischemia and hemorrhage: Animal models | 10 | |
| Theme C: Neurodegenerative Disorders and Injury | C.07. Ischemia | C.07.f. Inflammation | 14 | |
| Theme C: Neurodegenerative Disorders and Injury | C.07. Ischemia | C.07.g. Therapeutic, interventional and translational studies | 16 | |
| Theme C: Neurodegenerative Disorders and Injury | C.08.Stroke | C.08.a. Stroke, damage, or disease: Assessment and treatment | 46 | |
| Theme C: Neurodegenerative Disorders and Injury | C.08.Stroke | C.08.b. Stroke, damage, or disease: Mechanisms of abnormal movement | 17 | |
| Theme C: Neurodegenerative Disorders and Injury | C.08.Stroke | C.08.c. Stroke imaging and diagnostic studies | 21 | |
| Theme C: Neurodegenerative Disorders and Injury | C.08.Stroke | C.08.d. Stroke recovery: Pharmacological approaches to therapy | 28 | |
| Theme C: Neurodegenerative Disorders and Injury | C.08.Stroke | C.08.e. Stroke recovery: Non-pharmacological approaches to therapy | 30 | |
| Theme C: Neurodegenerative Disorders and Injury | C.09. Brain Injury and Trauma | C.09.a. Brain: Cellular molecular mechanisms | 40 | |
| Theme C: Neurodegenerative Disorders and Injury | C.09. Brain Injury and Trauma | C.09.b. Brain: Animal models of brain injury | 99 | |
| Theme C: Neurodegenerative Disorders and Injury | C.09. Brain Injury and Trauma | C.09.c. Brain: Emerging models of brain injury | 7 | |
| Theme C: Neurodegenerative Disorders and Injury | C.09. Brain Injury and Trauma | C.09.d. Brain: Human studies | 38 | |
| Theme C: Neurodegenerative Disorders and Injury | C.09. Brain Injury and Trauma | C.09.e. Brain: Therapeutic strategies | 68 | |
| Theme C: Neurodegenerative Disorders and Injury | C.09. Brain Injury and Trauma | C.09.f. Spinal cord: Cellular and molecular mechanisms | 32 | |
| Theme C: Neurodegenerative Disorders and Injury | C.09. Brain Injury and Trauma | C.09.g. Spinal cord: Animal models and human studies | 43 | |
| Theme C: Neurodegenerative Disorders and Injury | C.09. Brain Injury and Trauma | C.09.h. Spinal cord: Therapeutic strategies: In vivo | 42 | |
| Theme C: Neurodegenerative Disorders and Injury | C.09. Brain Injury and Trauma | C.09.i. Peripheral nerve trauma, crush and toxic injury | 17 | |
| Theme C: Neurodegenerative Disorders and Injury | C.09. Brain Injury and Trauma | C.09.j. Spinal cord: Therapeutic strategies: In vitro studies | 8 | |
| Theme C: Neurodegenerative Disorders and Injury | C.09. Brain Injury and Trauma | C.09.k. Acute therapy | 2 | |
| Theme C: Neurodegenerative Disorders and Injury | C.10.Tauopathies, Tau-dementias, and Prion diseases | C.10.a. Cellular and molecular mechanisms | 20 | |
| Theme C: Neurodegenerative Disorders and Injury | C.10.Tauopathies, Tau-dementias, and Prion diseases | C.10.b. Animal models | 12 | |
| Theme C: Neurodegenerative Disorders and Injury | C.10.Tauopathies, Tau-dementias, and Prion diseases | C.10.c. Preclinical and clinical therapeutic approaches | 1 | |
| Theme C: Neurodegenerative Disorders and Injury | C.10.Tauopathies, Tau-dementias, and Prion diseases | C.10.d. Transmission mechanisms and properties | 3 | |
| Theme D: Sensory Systems | D.01. Sensory Disorders | D.01.a. Visual and auditory | 9 | |
| Theme D: Sensory Systems | D.02. Somatosensation | D.02.a. Spinal cord processing: Anatomy and physiology | 17 | |
| Theme D: Sensory Systems | D.02. Somatosensation | D.02.b. Spinal cord processing: Pharmacology | 4 | |
| Theme D: Sensory Systems | D.03. Somatosensation: Pain | D.03.a. Somatosensory transduction: TRP channels | 20 | |
| Theme D: Sensory Systems | D.03. Somatosensation: Pain | D.03.b. Nociceptors | 41 | |
| Theme D: Sensory Systems | D.03. Somatosensation: Pain | D.03.c. Trigeminal processing | 13 | |
| Theme D: Sensory Systems | D.03. Somatosensation: Pain | D.03.d. Headache and migraine | 13 | |
| Theme D: Sensory Systems | D.03. Somatosensation: Pain | D.03.e. Thalamic and cortical processing | 8 | |
| Theme D: Sensory Systems | D.03. Somatosensation: Pain | D.03.f. Descending modulation | 24 | |
| Theme D: Sensory Systems | D.03. Somatosensation: Pain | D.03.g. Treatments for persistent pain | 31 | |
| Theme D: Sensory Systems | D.03. Somatosensation: Pain | D.03.h. Pain models: Pharmacology | 42 | |
| Theme D: Sensory Systems | D.03. Somatosensation: Pain | D.03.i. Pain models: Behavior | 45 | |
| Theme D: Sensory Systems | D.03. Somatosensation: Pain | D.03.j. Pain models: Physiology | 18 | |
| Theme D: Sensory Systems | D.03. Somatosensation: Pain | D.03.k. Inflammatory pain | 22 | |
| Theme D: Sensory Systems | D.03. Somatosensation: Pain | D.03.l. Mechanisms of peripheral neuropathic pain | 65 | |
| Theme D: Sensory Systems | D.03. Somatosensation: Pain | D.03.m. Mechanisms of central neuropathic pain | 16 | |
| Theme D: Sensory Systems | D.03. Somatosensation: Pain | D.03.n. Visceral and musculoskeletal pain | 10 | |
| Theme D: Sensory Systems | D.03. Somatosensation: Pain | D.03.o. Pain imaging and perception | 33 | |
| Theme D: Sensory Systems | D.03. Somatosensation: Pain | D.03.p. Opioid receptor pharmacology and signaling mechanisms | 25 | |
| Theme D: Sensory Systems | D.03. Somatosensation: Pain | D.03.q. Other analgesics | 8 | |
| Theme D: Sensory Systems | D.04. Somatosensation: Touch | D.04.a. Transduction mechanisms | 12 | |
| Theme D: Sensory Systems | D.04. Somatosensation: Touch | D.04.b. Plasticity and reorganization | 9 | |
| Theme D: Sensory Systems | D.04. Somatosensation: Touch | D.04.c. Thalamic and cortical processing | 24 | |
| Theme D: Sensory Systems | D.04. Somatosensation: Touch | D.04.d. Barrel cortex | 29 | |
| Theme D: Sensory Systems | D.04. Somatosensation: Touch | D.04.e. Functional organization | 6 | |
| Theme D: Sensory Systems | D.04. Somatosensation: Touch | D.04.f. Stimulus feature receptive fields and response properties | 14 | |
| Theme D: Sensory Systems | D.04. Somatosensation: Touch | D.04.g. Stimulus feature neural coding | 11 | |
| Theme D: Sensory Systems | D.05. Olfaction and Taste | D.05.a. Olfactory receptor cells and transduction | 13 | |
| Theme D: Sensory Systems | D.05. Olfaction and Taste | D.05.b. Olfactory coding: Second order regions (olfactory bulb and antennal lobe) | 48 | |
| Theme D: Sensory Systems | D.05. Olfaction and Taste | D.05.c. Olfaction: Higher-order circuits | 24 | |
| Theme D: Sensory Systems | D.05. Olfaction and Taste | D.05.d. Olfaction: Behavior, perception, and its relation to neurophysiology | 26 | |
| Theme D: Sensory Systems | D.05. Olfaction and Taste | D.05.e. Taste | 17 | |
| Theme D: Sensory Systems | D.06. Audition | D.06.a. Mechanoreceptors and cochlea | 7 | |
| Theme D: Sensory Systems | D.06. Audition | D.06.b. Auditory processing: Sound localization and binaural interactions | 11 | |
| Theme D: Sensory Systems | D.06. Audition | D.06.c. Auditory processing: Temporal, frequency, and spectral processing | 28 | |
| Theme D: Sensory Systems | D.06. Audition | D.06.d. Auditory processing: Vocalizations and natural sounds | 21 | |
| Theme D: Sensory Systems | D.06. Audition | D.06.e. Auditory processing: Circuits, synapses, and neurotransmitters | 36 | |
| Theme D: Sensory Systems | D.06. Audition | D.06.f. Auditory processing: Adaptation, learning, and memory | 15 | |
| Theme D: Sensory Systems | D.06. Audition | D.06.g. Auditory processing: Neural coding, experiment, and theory | 26 | |
| Theme D: Sensory Systems | D.06. Audition | D.06.h. Auditory processing: Perception, cognition, and action | 56 | |
| Theme D: Sensory Systems | D.07. Vision | D.07.a. Retina: Photoreceptors | 9 | |
| Theme D: Sensory Systems | D.07. Vision | D.07.b. Retinal circuitry | 35 | |
| Theme D: Sensory Systems | D.07. Vision | D.07.c. Subcortical visual pathways | 43 | |
| Theme D: Sensory Systems | D.07. Vision | D.07.d. Striate cortex: Circuitry and organization | 68 | |
| Theme D: Sensory Systems | D.07. Vision | D.07.e. Striate cortex: Response properties | 64 | |
| Theme D: Sensory Systems | D.07. Vision | D.07.f. Striate cortex: Plasticity | 29 | |
| Theme D: Sensory Systems | D.07. Vision | D.07.g. Extrastriate cortex | 49 | |
| Theme D: Sensory Systems | D.07. Vision | D.07.h. Processing of contrast, form, and color | 20 | |
| Theme D: Sensory Systems | D.07. Vision | D.07.i. Visual motion | 34 | |
| Theme D: Sensory Systems | D.07. Vision | D.07.j. Representation of objects and scenes | 26 | |
| Theme D: Sensory Systems | D.07. Vision | D.07.k. Representation of faces and bodies | 19 | |
| Theme D: Sensory Systems | D.07. Vision | D.07.l. Visual learning, memory, and categorization | 17 | |
| Theme D: Sensory Systems | D.07. Vision | D.07.m. Spatial and feature-based attention | 17 | |
| Theme D: Sensory Systems | D.07. Vision | D.07.n. Visual cognition: Decision making | 30 | |
| Theme D: Sensory Systems | D.08. Vestibular System | D.08.a. Vestibular hair cells, end organs, and nerve | 6 | |
| Theme D: Sensory Systems | D.08. Vestibular System | D.08.b. Vestibular central physiology and anatomy | 11 | |
| Theme D: Sensory Systems | D.08. Vestibular System | D.08.c. Vestibular perception, posture, and spatial orientation | 9 | |
| Theme D: Sensory Systems | D.09. Visual Sensory-motor Processing | D.09.a. Eye movements and perception | 18 | |
| Theme D: Sensory Systems | D.09. Visual Sensory-motor Processing | D.09.b. Sensorimotor transformation: Behavior and whole animal | 20 | |
| Theme D: Sensory Systems | D.09. Visual Sensory-motor Processing | D.09.c. Sensorimotor transformation: Neuroprocessing | 22 | |
| Theme D: Sensory Systems | D.09. Visual Sensory-motor Processing | D.09.d. Visually-guided reaching | 14 | |
| Theme D: Sensory Systems | D.10. Multisensory Integration | D.10.a. Cross-modal processing: Spatial factors | 13 | |
| Theme D: Sensory Systems | D.10. Multisensory Integration | D.10.b. Cross-modal processing: Temporal factors | 12 | |
| Theme D: Sensory Systems | D.10. Multisensory Integration | D.10.c. Cross-modal processing: Neural circuitry and development | 32 | |
| Theme D: Sensory Systems | D.10. Multisensory Integration | D.10.d. Cross-modal processing: In humans | 27 | |
| Theme E: Motor Systems | E.01. Eye Movements | E.01.a. Eye movements: Central mechanisms | 15 | |
| Theme E: Motor Systems | E.01. Eye Movements | E.01.b. Eye movements: Saccades | 29 | |
| Theme E: Motor Systems | E.01. Eye Movements | E.01.c. Eye movements: Perception and neural mechanisms | 7 | |
| Theme E: Motor Systems | E.02. Cerebellum | E.02.a. Cerebellum: Cortex and nuclei | 42 | |
| Theme E: Motor Systems | E.02. Cerebellum | E.02.b. Cerebellum: Plasticity and climbing fibers | 10 | |
| Theme E: Motor Systems | E.02. Cerebellum | E.02.c. Cerebellum: Human studies | 2 | |
| Theme E: Motor Systems | E.03. Basal Ganglia | E.03.a. Transmitters and neuromodulation | 21 | |
| Theme E: Motor Systems | E.03. Basal Ganglia | E.03.b. Cellular physiology | 19 | |
| Theme E: Motor Systems | E.03. Basal Ganglia | E.03.c. Systems physiology and plasticity | 26 | |
| Theme E: Motor Systems | E.03. Basal Ganglia | E.03.d. Systems behavior | 34 | |
| Theme E: Motor Systems | E.04. Voluntary Movements | E.04.a. Finger and grasp control: Normal human behavior | 24 | |
| Theme E: Motor Systems | E.04. Voluntary Movements | E.04.b. Finger and grasp control: Age, pathology, and physiology | 17 | |
| Theme E: Motor Systems | E.04. Voluntary Movements | E.04.c. Reaching control: Action and sensation | 16 | |
| Theme E: Motor Systems | E.04. Voluntary Movements | E.04.d. Reaching control: Movement selection and strategy | 27 | |
| Theme E: Motor Systems | E.04. Voluntary Movements | E.04.e. Reaching control: Motor learning: Human | 58 | |
| Theme E: Motor Systems | E.04. Voluntary Movements | E.04.f. Reaching control: Motor learning: Animal | 9 | |
| Theme E: Motor Systems | E.04. Voluntary Movements | E.04.g. Interlimb and bimanual control | 25 | |
| Theme E: Motor Systems | E.04. Voluntary Movements | E.04.h. Cortical planning and execution: Behavior | 32 | |
| Theme E: Motor Systems | E.04. Voluntary Movements | E.04.i. Cortical planning and execution: Neurophysiology: Human | 25 | |
| Theme E: Motor Systems | E.04. Voluntary Movements | E.04.j. Cortical planning and execution: Neurophysiology: Animal | 40 | |
| Theme E: Motor Systems | E.04. Voluntary Movements | E.04.k. Cortical planning and execution: Neuroimaging | 13 | |
| Theme E: Motor Systems | E.04. Voluntary Movements | E.04.l. Oral motor and speech | 22 | |
| Theme E: Motor Systems | E.04. Voluntary Movements | E.04.m. Plasticity | 18 | |
| Theme E: Motor Systems | E.05. Brain-Machine Interface | E.05.a. Neurophysiology: Non-invasive mechanisms | 25 | |
| Theme E: Motor Systems | E.05. Brain-Machine Interface | E.05.b. Neurophysiology: Implanted electrodes and other direct interactions with neurons | 57 | |
| Theme E: Motor Systems | E.05. Brain-Machine Interface | E.05.c. Neurophysiology: Neural processing | 22 | |
| Theme E: Motor Systems | E.05. Brain-Machine Interface | E.05.d. Neuroprosthetics: Control of real and artificial arm, hand, other grasping devices | 33 | |
| Theme E: Motor Systems | E.05. Brain-Machine Interface | E.05.e. Neuroprosthetics: Other motor sensory interfaces (e.g., artificial vision) | 10 | |
| Theme E: Motor Systems | E.06. Posture and Gait | E.06.a. Posture and gait: Kinematics, muscle activity, exercise and fatigue, and biomechanics | 49 | |
| Theme E: Motor Systems | E.06. Posture and Gait | E.06.b. Posture and gait: Afferent control | 13 | |
| Theme E: Motor Systems | E.06. Posture and Gait | E.06.c. Posture and gait: Higher order control, multi-task integration, and theory | 24 | |
| Theme E: Motor Systems | E.06. Posture and Gait | E.06.d. Posture and gait: Aging, injury, and disease | 28 | |
| Theme E: Motor Systems | E.06. Posture and Gait | E.06.e. Reflexes and reflex modulation | 12 | |
| Theme E: Motor Systems | E.07. Rhythmic Motor Pattern Generation | E.07.a. Cellular properties: Interneurons and motor neurons | 37 | |
| Theme E: Motor Systems | E.07. Rhythmic Motor Pattern Generation | E.07.b. Connectivity | 13 | |
| Theme E: Motor Systems | E.07. Rhythmic Motor Pattern Generation | E.07.c. Neuromodulation | 22 | |
| Theme E: Motor Systems | E.07. Rhythmic Motor Pattern Generation | E.07.d. Afferent and descending control | 16 | |
| Theme E: Motor Systems | E.08. Respiratory Regulation | E.08.a. Respiratory regulation: Central respiratory chemoreception | 11 | |
| Theme E: Motor Systems | E.08. Respiratory Regulation | E.08.b. Respiratory regulation: Respiratory rhythm and pattern generation | 16 | |
| Theme E: Motor Systems | E.08. Respiratory Regulation | E.08.c. Respiratory regulation: Hypoxia and obstructive sleep apnea | 4 | |
| Theme E: Motor Systems | E.09. Spinal Cord Injury and Plasticity | E.09.a. Spinal cord injury: Posture and locomotion | 13 | |
| Theme E: Motor Systems | E.09. Spinal Cord Injury and Plasticity | E.09.b. Spinal cord injury: Recovery | 27 | |
| Theme E: Motor Systems | E.09. Spinal Cord Injury and Plasticity | E.09.c. Spinal cord injury: Training, rehabilitation, and repair | 43 | |
| Theme E: Motor Systems | E.09. Spinal Cord Injury and Plasticity | E.09.d. Neurophysiology | 20 | |
| Theme E: Motor Systems | E.10. Motor Neurons and Muscle | E.10.a. Motor neurons: Activity, sensory, and central control: Exercise, injury, and disease | 30 | |
| Theme E: Motor Systems | E.10. Motor Neurons and Muscle | E.10.b. Motor neurons: Development, identification, intrinsic properties, and modulation | 12 | |
| Theme E: Motor Systems | E.10. Motor Neurons and Muscle | E.10.c. Motor unit recordings, kinematics, and EMG | 22 | |
| Theme E: Motor Systems | E.10. Motor Neurons and Muscle | E.10.d. Motorneuron-muscle interface | 15 | |
| Theme E: Motor Systems | E.10. Motor Neurons and Muscle | E.10.e. Muscle physiology and biochemistry | 4 | |
| Theme F: Integrative Physiology and Behavior | F.01. Neuroethology | F.01.a. Sensory and motor systems | 77 | |
| Theme F: Integrative Physiology and Behavior | F.01. Neuroethology | F.01.b. Vocal/social communication: Avian | 58 | |
| Theme F: Integrative Physiology and Behavior | F.01. Neuroethology | F.01.c. Vocal/social communication: Non-avian | 18 | |
| Theme F: Integrative Physiology and Behavior | F.02. Behavioral Neuroendocrinology | F.02.a. Sexual behavior | 21 | |
| Theme F: Integrative Physiology and Behavior | F.02. Behavioral Neuroendocrinology | F.02.b. Parental behavior | 21 | |
| Theme F: Integrative Physiology and Behavior | F.02. Behavioral Neuroendocrinology | F.02.c. Social behavior | 42 | |
| Theme F: Integrative Physiology and Behavior | F.02. Behavioral Neuroendocrinology | F.02.d. Defensive behavior and aggression | 6 | |
| Theme F: Integrative Physiology and Behavior | F.02. Behavioral Neuroendocrinology | F.02.e. Hormones and cognition | 50 | |
| Theme F: Integrative Physiology and Behavior | F.03. Neuroendocrine Processes | F.03.a. HPG axis: GnRH cells and gonadotrophins | 8 | |
| Theme F: Integrative Physiology and Behavior | F.03. Neuroendocrine Processes | F.03.b. HPG axis: Neural control | 13 | |
| Theme F: Integrative Physiology and Behavior | F.03. Neuroendocrine Processes | F.03.c. Neuroendocrine anatomy, physiology, and plasticity | 44 | |
| Theme F: Integrative Physiology and Behavior | F.03. Neuroendocrine Processes | F.03.d. Sexual differentiation | 17 | |
| Theme F: Integrative Physiology and Behavior | F.04. Stress and the Brain | F.04.a. Stress and neuroimmunology | 36 | |
| Theme F: Integrative Physiology and Behavior | F.04. Stress and the Brain | F.04.b. Cellular actions of stress | 33 | |
| Theme F: Integrative Physiology and Behavior | F.04. Stress and the Brain | F.04.c. Early-life stress: Neural, neurochemical, and physiologic effects | 34 | |
| Theme F: Integrative Physiology and Behavior | F.04. Stress and the Brain | F.04.d. Early-life stress: Molecular mechanisms and cellular effects | 14 | |
| Theme F: Integrative Physiology and Behavior | F.04. Stress and the Brain | F.04.e. Early-life stress: Effects on anxiety, social function, and depression | 27 | |
| Theme F: Integrative Physiology and Behavior | F.04. Stress and the Brain | F.04.f. Early-life stress: Adolescence | 16 | |
| Theme F: Integrative Physiology and Behavior | F.04. Stress and the Brain | F.04.g. Stress-modulated pathways: Cortex, hippocampus, and striatum | 49 | |
| Theme F: Integrative Physiology and Behavior | F.04. Stress and the Brain | F.04.h. Stress-modulated pathways: Hypothalamus, amygdala, and bed nucleus | 39 | |
| Theme F: Integrative Physiology and Behavior | F.04. Stress and the Brain | F.04.i. Stress-modulated pathways: Brainstem and other | 16 | |
| Theme F: Integrative Physiology and Behavior | F.04. Stress and the Brain | F.04.j. Stress and cognition | 35 | |
| Theme F: Integrative Physiology and Behavior | F.05. Neuroimmunology | F.05.a. Regulating systems | 17 | |
| Theme F: Integrative Physiology and Behavior | F.05. Neuroimmunology | F.05.b. Behavioral effects | 35 | |
| Theme F: Integrative Physiology and Behavior | F.06. Brain Blood Flow, Metabolism, and Homeostasis | F.06.a. Energy metabolism | 24 | |
| Theme F: Integrative Physiology and Behavior | F.06. Brain Blood Flow, Metabolism, and Homeostasis | F.06.b. Blood flow | 22 | |
| Theme F: Integrative Physiology and Behavior | F.06. Brain Blood Flow, Metabolism, and Homeostasis | F.06.c. Blood brain barrier | 20 | |
| Theme F: Integrative Physiology and Behavior | F.06. Brain Blood Flow, Metabolism, and Homeostasis | F.06.d. Functional imaging | 27 | |
| Theme F: Integrative Physiology and Behavior | F.07. Autonomic Regulation | F.07.a. Cardiovascular regulation | 38 | |
| Theme F: Integrative Physiology and Behavior | F.07. Autonomic Regulation | F.07.b. Gastrointestinal, renal/urinary, and reproductive regulation | 38 | |
| Theme F: Integrative Physiology and Behavior | F.07. Autonomic Regulation | F.07.c. Thermoregulation and other | 6 | |
| Theme F: Integrative Physiology and Behavior | F.08. Biological Rhythms and Sleep | F.08.a. Entrainment and phase shifts | 19 | |
| Theme F: Integrative Physiology and Behavior | F.08. Biological Rhythms and Sleep | F.08.b. Molecular biology and physiology of clocks | 11 | |
| Theme F: Integrative Physiology and Behavior | F.08. Biological Rhythms and Sleep | F.08.c. Sleep: Molecular, cellular, and pharmacology | 28 | |
| Theme F: Integrative Physiology and Behavior | F.08. Biological Rhythms and Sleep | F.08.d. Sleep: Regulators | 12 | |
| Theme F: Integrative Physiology and Behavior | F.08. Biological Rhythms and Sleep | F.08.e. Sleep: Systems | 37 | |
| Theme F: Integrative Physiology and Behavior | F.08. Biological Rhythms and Sleep | F.08.f. Sleep: Behavior | 34 | |
| Theme F: Integrative Physiology and Behavior | F.08. Biological Rhythms and Sleep | F.08.g. SCN anatomy, physiology, neurochemistry | 9 | |
| Theme F: Integrative Physiology and Behavior | F.09. Thirst and Water Balance | F.09.a. Thirst and water balance | 8 | |
| Theme F: Integrative Physiology and Behavior | F.10. Food Intake and Energy Balance | F.10.a. Integration of peripheral signals: Regulators | 18 | |
| Theme F: Integrative Physiology and Behavior | F.10. Food Intake and Energy Balance | F.10.b. Integration of peripheral signals: Systems | 18 | |
| Theme F: Integrative Physiology and Behavior | F.10. Food Intake and Energy Balance | F.10.c. Central pathways: Anatomy and development | 26 | |
| Theme F: Integrative Physiology and Behavior | F.10. Food Intake and Energy Balance | F.10.d. Neuropeptide regulators | 22 | |
| Theme F: Integrative Physiology and Behavior | F.10. Food Intake and Energy Balance | F.10.e. Monoamines, amino acids, and other regulators | 18 | |
| Theme G: Motivation and Emotion | G.01. Appetitive and Aversive Learning | G.01.a. Appetitive and incentive learning and memory | 39 | |
| Theme G: Motivation and Emotion | G.01. Appetitive and Aversive Learning | G.01.b. Fear and aversive learning and memory: Acquisition | 13 | |
| Theme G: Motivation and Emotion | G.01. Appetitive and Aversive Learning | G.01.c. Fear and aversive learning and memory: Modulation | 17 | |
| Theme G: Motivation and Emotion | G.01. Appetitive and Aversive Learning | G.01.d. Fear and aversive learning and memory: Extinction | 12 | |
| Theme G: Motivation and Emotion | G.01. Appetitive and Aversive Learning | G.01.e. Fear and aversive learning and memory: Neural circuitry | 42 | |
| Theme G: Motivation and Emotion | G.02. Motivation | G.02.a. Reward: Dopamine | 46 | |
| Theme G: Motivation and Emotion | G.02. Motivation | G.02.b. Reward: Motivational mechanisms | 80 | |
| Theme G: Motivation and Emotion | G.02. Motivation | G.02.c. Reward: Neuropharmacology | 14 | |
| Theme G: Motivation and Emotion | G.02. Motivation | G.02.d. Motivation: Subcortical neurocircuitry | 22 | |
| Theme G: Motivation and Emotion | G.02. Motivation | G.02.e. Motivation: Cortical neurocircuitry | 10 | |
| Theme G: Motivation and Emotion | G.02. Motivation | G.02.f. Motivation: Risk taking | 5 | |
| Theme G: Motivation and Emotion | G.02. Motivation | G.02.g. Motivation: Social communication and behavior | 35 | |
| Theme G: Motivation and Emotion | G.03. Emotion | G.03.a. Human emotion | 26 | |
| Theme G: Motivation and Emotion | G.03. Emotion | G.03.b. Emotion: Neurocircuitry | 61 | |
| Theme G: Motivation and Emotion | G.03. Emotion | G.03.c. Emotion: Fear, anxiety, and pain | 46 | |
| Theme G: Motivation and Emotion | G.03. Emotion | G.03.d. Emotion: Positive and negative emotional states | 26 | |
| Theme G: Motivation and Emotion | G.03. Emotion | G.03.e. Emotion: Information processing | 8 | |
| Theme G: Motivation and Emotion | G.04. Mood Disorders: Depression and Bipolar Disorders | G.04.a. Depression: Human postmortem studies | 3 | |
| Theme G: Motivation and Emotion | G.04. Mood Disorders: Depression and Bipolar Disorders | G.04.b. Depression: Human imaging and behavioral studies | 18 | |
| Theme G: Motivation and Emotion | G.04. Mood Disorders: Depression and Bipolar Disorders | G.04.c. Depression: Treatment and drug discovery | 47 | |
| Theme G: Motivation and Emotion | G.04. Mood Disorders: Depression and Bipolar Disorders | G.04.d. Depression: Animal models of mechanisms | 69 | |
| Theme G: Motivation and Emotion | G.04. Mood Disorders: Depression and Bipolar Disorders | G.04.e. Depression: Animal models of therapeutics | 42 | |
| Theme G: Motivation and Emotion | G.04. Mood Disorders: Depression and Bipolar Disorders | G.04.f. Bipolar disorders | 7 | |
| Theme G: Motivation and Emotion | G.05. Anxiety Disorders | G.05.a. Human studies | 8 | |
| Theme G: Motivation and Emotion | G.05. Anxiety Disorders | G.05.b. Preclinical models | 34 | |
| Theme G: Motivation and Emotion | G.05. Anxiety Disorders | G.05.c Therapeutic approaches | 5 | |
| Theme G: Motivation and Emotion | G.06. Post-traumatic Stress Disorder | G.06.a. Human studies | 10 | |
| Theme G: Motivation and Emotion | G.06. Post-traumatic Stress Disorder | G.06.b. Preclinical models | 40 | |
| Theme G: Motivation and Emotion | G.07. Other Psychiatric Disorders | G.07.a. OCD and repetitive behaviors | 9 | |
| Theme G: Motivation and Emotion | G.07. Other Psychiatric Disorders | G.07.b. Eating disorders | 8 | |
| Theme G: Motivation and Emotion | G.07. Other Psychiatric Disorders | G.07.c. Other disorders | 20 | |
| Theme G: Motivation and Emotion | G.08. Drugs of Abuse and Addiction | G.08.a. Addictive drugs: Developmental effects | 12 | |
| Theme G: Motivation and Emotion | G.08. Drugs of Abuse and Addiction | G.08.b. Addictive drugs: Drug tolerance, dependence, and toxicity | 17 | |
| Theme G: Motivation and Emotion | G.08. Drugs of Abuse and Addiction | G.08.c. Addiction: Genetics | 20 | |
| Theme G: Motivation and Emotion | G.08. Drugs of Abuse and Addiction | G.08.d. Addiction treatment: Translational and clinical studies | 15 | |
| Theme G: Motivation and Emotion | G.08. Drugs of Abuse and Addiction | G.08.e. Learning, memory, and addiction | 37 | |
| Theme G: Motivation and Emotion | G.08. Drugs of Abuse and Addiction | G.08.f. Alcohol: Intake and preference | 38 | |
| Theme G: Motivation and Emotion | G.08. Drugs of Abuse and Addiction | G.08.g. Alcohol: Other behavioral effects | 17 | |
| Theme G: Motivation and Emotion | G.08. Drugs of Abuse and Addiction | G.08.h. Alcohol: Neural mechanisms | 40 | |
| Theme G: Motivation and Emotion | G.08. Drugs of Abuse and Addiction | G.08.i. Amphetamines: Reinforcement, seeking, and reinstatement | 19 | |
| Theme G: Motivation and Emotion | G.08. Drugs of Abuse and Addiction | G.08.j. Amphetamines: Other behavioral effects | 9 | |
| Theme G: Motivation and Emotion | G.08. Drugs of Abuse and Addiction | G.08.k. Amphetamines: Neural mechanisms of addiction | 20 | |
| Theme G: Motivation and Emotion | G.08. Drugs of Abuse and Addiction | G.08.l. Cannabinoids: Neural mechanisms and addiction | 17 | |
| Theme G: Motivation and Emotion | G.08. Drugs of Abuse and Addiction | G.08.m. Cocaine reinforcement | 17 | |
| Theme G: Motivation and Emotion | G.08. Drugs of Abuse and Addiction | G.08.n. Cocaine seeking and reinstatement | 41 | |
| Theme G: Motivation and Emotion | G.08. Drugs of Abuse and Addiction | G.08.o. Cocaine: Other behavioral studies | 14 | |
| Theme G: Motivation and Emotion | G.08. Drugs of Abuse and Addiction | G.08.p. Cocaine: Neural mechanisms of addiction | 68 | |
| Theme G: Motivation and Emotion | G.08. Drugs of Abuse and Addiction | G.08.q. Opioid reinforcement, seeking, and reinstatement | 16 | |
| Theme G: Motivation and Emotion | G.08. Drugs of Abuse and Addiction | G.08.r. Opioids: Neural mechanisms of addiction | 21 | |
| Theme G: Motivation and Emotion | G.08. Drugs of Abuse and Addiction | G.08.s. Nicotine: Reinforcement, seeking, and reinstatement | 14 | |
| Theme G: Motivation and Emotion | G.08. Drugs of Abuse and Addiction | G.08.t. Nicotine: Neural mechanisms of addiction | 25 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.a. Functional mechanisms of attention | 29 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.aa. Cortical and hippocampal circuits: Grid cells | 6 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.b. Decision making: Prefrontal cortex | 64 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.bb. Thalamic and brainstem circuits | 8 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.c. Decision making: Corticolimbic circuits | 24 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.cc. Cortical and striatal circuits | 39 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.d. Executive function: Learning and memory | 75 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.dd. Associative, nonassociative, and skill learning | 14 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.e. Executive function: Network activity | 20 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.f. Executive function: Models of disorders | 13 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.g. Executive function: Inhibitory control | 14 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.h. Memory consolidation and reconsolidation: Behavior | 37 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.i. Memory consolidation and reconsolidation: Molecular mechanisms | 10 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.j. Memory consolidation and reconsolidation: Neural circuit mechanisms | 18 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.k. Learning and memory: Intrahippocampal circuits | 3 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.l. Learning and memory: Cortical-hippocampal interactions | 49 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.m. Learning and memory: Hippocampal circuits | 89 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.n. Learning and memory: Dentate gyrus | 11 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.o. Learning and memory: Entorhinal cortex | 7 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.p. Learning and memory: Molecular mechanisms | 49 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.q. Learning and memory: Neural circuit mechanisms | 60 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.r. Learning and memory: Gamma and theta rhythms | 10 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.s. Learning and memory: Genes and signaling | 15 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.t. Learning and memory: Physiology | 15 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.u. Learning and memory: Pharmacology | 21 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.v. Learning and memory: Aging | 49 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.w. Learning and memory: Invertebrates | 16 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.x. Cortical and hippocampal circuits: Timing and temporal processing | 33 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.y. Cortical and hippocampal circuits: Spatial navigation | 87 | |
| Theme H: Cognition | H.01. Animal Cognition and Behavior | H.01.z. Cortical and hippocampal circuits: Place cells | 24 | |
| Theme H: Cognition | H.02. Human Cognition and Behavior | H.02.a. Perception and imagery | 34 | |
| Theme H: Cognition | H.02. Human Cognition and Behavior | H.02.b. Human learning: Perceptual and spatial learning | 16 | |
| Theme H: Cognition | H.02. Human Cognition and Behavior | H.02.c. Human learning: Motor and sequence learning | 19 | |
| Theme H: Cognition | H.02. Human Cognition and Behavior | H.02.d. Human learning: Feedback, reinforcement, and reward | 35 | |
| Theme H: Cognition | H.02. Human Cognition and Behavior | H.02.e. Human long-term memory: Medial temporal lobe | 63 | |
| Theme H: Cognition | H.02. Human Cognition and Behavior | H.02.f. Human long-term memory: Retrieval | 24 | |
| Theme H: Cognition | H.02. Human Cognition and Behavior | H.02.g. Human long-term memory: Encoding | 49 | |
| Theme H: Cognition | H.02. Human Cognition and Behavior | H.02.h. Human long-term memory: Encoding-retrieval interactions | 70 | |
| Theme H: Cognition | H.02. Human Cognition and Behavior | H.02.i. Functional mechanisms of attention | 34 | |
| Theme H: Cognition | H.02. Human Cognition and Behavior | H.02.j. Attentional networks | 18 | |
| Theme H: Cognition | H.02. Human Cognition and Behavior | H.02.k. Executive function | 59 | |
| Theme H: Cognition | H.02. Human Cognition and Behavior | H.02.l. Language | 43 | |
| Theme H: Cognition | H.02. Human Cognition and Behavior | H.02.m. Working memory | 43 | |
| Theme H: Cognition | H.02. Human Cognition and Behavior | H.02.n. Decision making and reasoning: Cognition and computational models | 50 | |
| Theme H: Cognition | H.02. Human Cognition and Behavior | H.02.o. Decision making and reasoning: Neural mechanisms | 38 | |
| Theme H: Cognition | H.02. Human Cognition and Behavior | H.02.p. Cognitive development | 18 | |
| Theme H: Cognition | H.02. Human Cognition and Behavior | H.02.q. Cognitive aging | 35 | |
| Theme H: Cognition | H.02. Human Cognition and Behavior | H.02.r. Individual differences | 24 | |
| Theme H: Cognition | H.02. Human Cognition and Behavior | H.02.s. Timing and temporal processing | 27 | |
| Theme H: Cognition | H.02. Human Cognition and Behavior | H.02.t. Social cognition: Behavior and pharmacology | 14 | |
| Theme H: Cognition | H.02. Human Cognition and Behavior | H.02.u. Social cognition: Neural processes and disorders | 22 | |
| Theme H: Cognition | H.03. Schizophrenia | H.03.a. Neuropathology | 21 | |
| Theme H: Cognition | H.03. Schizophrenia | H.03.b. Genetics and genomics | 12 | |
| Theme H: Cognition | H.03. Schizophrenia | H.03.c. Behavior and symptoms | 23 | |
| Theme H: Cognition | H.03. Schizophrenia | H.03.d. Circuits and systems | 21 | |
| Theme H: Cognition | H.03. Schizophrenia | H.03.e. Animal models: Developmental | 24 | |
| Theme H: Cognition | H.03. Schizophrenia | H.03.f. Animal models: Pharmacological | 23 | |
| Theme H: Cognition | H.03. Schizophrenia | H.03.g. Biochemical studies | 10 | |
| Theme H: Cognition | H.03. Schizophrenia | H.03.h. Therapeutics | 6 | |
| Theme I: Techniques | I.01. Molecular, Biochemical, and Genetic Techniques | I.01.a. Biochemical techniques | 8 | |
| Theme I: Techniques | I.01. Molecular, Biochemical, and Genetic Techniques | I.01.b. Molecular techniques | 38 | |
| Theme I: Techniques | I.01. Molecular, Biochemical, and Genetic Techniques | I.01.c. Genetic techniques | 25 | |
| Theme I: Techniques | I.02. Systems Biology and Bioinformatics | I.02.a. Genomics, proteomics, and systems biology | 16 | |
| Theme I: Techniques | I.02. Systems Biology and Bioinformatics | I.02.b. Bioinformatics | 15 | |
| Theme I: Techniques | I.03. Anatomical Methods | I.03.a. Staining, tracing, and imaging techniques: Sample preparation | 14 | |
| Theme I: Techniques | I.03. Anatomical Methods | I.03.b. Staining, tracing, and imaging techniques: Image acquisition | 47 | |
| Theme I: Techniques | I.03. Anatomical Methods | I.03.c. Staining, tracing, and imaging techniques: Circuit tracing | 29 | |
| Theme I: Techniques | I.03. Anatomical Methods | I.03.d. Staining, tracing, and imaging techniques: Electron microscopy | 10 | |
| Theme I: Techniques | I.03. Anatomical Methods | I.03.e. Staining, tracing, and imaging techniques: Novel probes | 14 | |
| Theme I: Techniques | I.04. Physiological Methods | I.04.a. Optical methodology: Development | 46 | |
| Theme I: Techniques | I.04. Physiological Methods | I.04.b. Optical methodology: Application | 22 | |
| Theme I: Techniques | I.04. Physiological Methods | I.04.c. Optical methodology: Probes | 13 | |
| Theme I: Techniques | I.04. Physiological Methods | I.04.d. Optogenetics | 52 | |
| Theme I: Techniques | I.04. Physiological Methods | I.04.e. Electrophysiology: Cellular | 8 | |
| Theme I: Techniques | I.04. Physiological Methods | I.04.f. Electrophysiology: Neural networks | 8 | |
| Theme I: Techniques | I.04. Physiological Methods | I.04.g. Electrophysiology: Electrode arrays | 54 | |
| Theme I: Techniques | I.04. Physiological Methods | I.04.h. Electrophysiology: Stimulating neurons | 23 | |
| Theme I: Techniques | I.04. Physiological Methods | I.04.i. Novel assays | 12 | |
| Theme I: Techniques | I.05. Biomarker and Drug Discovery | I.05.a. Affective disorders and schizophrenia | 6 | |
| Theme I: Techniques | I.05. Biomarker and Drug Discovery | I.05.b. Neurodegenerative diseases (AD, PD, MS, stroke) | 29 | |
| Theme I: Techniques | I.05. Biomarker and Drug Discovery | I.05.c. Drug delivery | 8 | |
| Theme I: Techniques | I.06. Computation, Modeling, and Simulation | I.06.a. Cellular models | 18 | |
| Theme I: Techniques | I.06. Computation, Modeling, and Simulation | I.06.b. Network models: Theory | 41 | |
| Theme I: Techniques | I.06. Computation, Modeling, and Simulation | I.06.c. Network models: Experimentation | 20 | |
| Theme I: Techniques | I.06. Computation, Modeling, and Simulation | I.06.d. Computational tools | 87 | |
| Theme I: Techniques | I.07. Data Analysis and Statistics | I.07.a. Data analysis and statistics: Human data | 46 | |
| Theme I: Techniques | I.07. Data Analysis and Statistics | I.07.b. Data analysis and statistics: Neuronal networks | 30 | |
| Theme I: Techniques | I.07. Data Analysis and Statistics | I.07.c. Software tools | 47 | |
| Theme J: History and Education | J.01. History of Neuroscience | J.01.a. History of neuroscience | 17 | |
| Theme J: History and Education | J.02. Teaching of Neuroscience | J.02.a. K-12 | 13 | |
| Theme J: History and Education | J.02. Teaching of Neuroscience | J.02.b. College | 46 | |
| Theme J: History and Education | J.02. Teaching of Neuroscience | J.02.c. Graduate and professional | 10 | |
| Theme J: History and Education | J.03. Public Awareness of Neuroscience | J.03.a. Outreach activities | 42 | |
| Theme J: History and Education | J.04. Ethical and Policy Issues in Neuroscience | J.04.a. Ethical and policy issues in neuroscience | 13 |
Sign up for free
to join this conversation on GitHub.
Already have an account?
Sign in to comment